Cite
HARVARD Citation
Blann, A. et al. (2015). Net clinical benefit of edoxaban versus no treatment in a 'real world' atrial fibrillation population: A modelling analysis based on a nationwide cohort study. International journal of cardiology. pp. 693-698. [Online].